Global Financial Private Client’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-118
Closed -$10.6K 1035
2025
Q1
$10.6K Buy
118
+31
+36% +$2.77K ﹤0.01% 566
2024
Q4
$6.95K Sell
87
-40
-31% -$3.46K ﹤0.01% 606
2024
Q3
$11.4K Buy
127
+105
+477% +$8.83K ﹤0.01% 528
2024
Q2
$1.73K Sell
22
-70
-76% -$5.74K ﹤0.01% 584
2024
Q1
$8.01K Hold
92
﹤0.01% 484
2023
Q4
$7.58K Hold
92
﹤0.01% 485
2023
Q3
$7.16K Hold
92
﹤0.01% 474
2023
Q2
$8.02K Sell
92
-297
-76% -$25.6K ﹤0.01% 463
2023
Q1
$31K Buy
389
+195
+101% +$15.9K 0.02% 333
2022
Q4
$15.1K Buy
194
+124
+177% +$10.1K 0.01% 379
2022
Q3
$5.79K Hold
70
﹤0.01% 458
2022
Q2
$6.4K Hold
70
﹤0.01% 441
2022
Q1
$7.88K Hold
70
﹤0.01% 433
2021
Q4
$7.24K Buy
+70
New +$8.11K ﹤0.01% 423

Other funds holding MDT

Global Financial Private Client's MDT Position: Q2 2025 in Review

Global Financial Private Client sold out of Medtronic (MDT) in Q2 2025, closing a stake of 118 shares — an estimated $10.6K sold.

Global Financial Private Client first reported a position in MDT in Q4 2021 and held it in 14 quarters. The position peaked at $31K in Q1 2023. 2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Global Financial Private Client reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 118 Medtronic shares in Q2 2025, an estimated $10.6K.
  • Global Financial Private Client first reported a position in Medtronic in Q4 2021 and held it in 14 quarters.
  • Global Financial Private Client's Medtronic position peaked at $31K in Q1 2023.
  • 2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.